Real-world utilization of cabotegravir plus rilpivirine in Southern Spain: data from the CARIPLA study

被引：0
|
作者：
Palacios, Rosario [1 ]
Gomez-Ayerbe, Cristina [1 ]
Mayorga, Marisa [2 ]
Espinosa, Nuria [3 ]
Hidalgo, Alicia [4 ]
Tellez, Francisco [5 ]
Lozano, Ana Belen [6 ]
Loring, Monica
Santos, Jesus [1 ,7 ]
机构：
[1] Hosp Univ Virgen Victoria, Infect Dis Unit, Malaga, Spain
[2] Hosp Reg Carlos Haya, Infect Dis Unit, Malaga, Spain
[3] Hosp Virgen Rocio, Infect Dis Unit, Seville, Spain
[4] Hosp Juan Ramon Jimenez, Infect Dis Unit, Huelva, Spain
[5] Hosp Puerto Real, Infect Dis, Cadiz, Spain
[6] Hosp El Ejido, Infect Dis Unit, Almeria, Spain
[7] Hosp Axarquia, Internal Med, Malaga, Spain
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2024年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P084
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [1] Real-world effectiveness of cabotegravir plus rilpivirine in virologically suppressed treatment experienced individuals in Europe: Data from COMBINE-2 study
    Pozniak, A.
    Sridhar, G.
    Assoumou, L.
    Piroth, L.
    Braun, D.
    Fletcher, C.
    Ragone, L.
    Shah, A.
    van Wyk, J.
    Vannappagari, V.
    HIV MEDICINE, 2023, 24 : 143 - 144
  • [2] Real-world outcomes of cabotegravir and rilpivirine for treating PLHIV in Spain: a multicentre, ambispective and nationwide study (the RELATIVITY cohort)
    Buzon Martin, Luis
    Luisa Montes, Maria
    Galindo Puerto, Maria J.
    Torralba Gonzalez, Miguel
    Pousada, Guillermo
    Santacreu, Mireia
    de los Santos, Ignacio
    Cabello Ubeda, Alfonso
    Cabello Clotet, Noemi
    Crusells-Canales, Maria Jose
    Enrique Morano, Luis
    Martin Rico, Patricia
    Montero Hernandez, Carmen
    Diaz de Santiago, Alberto
    Cecilio, Alvaro
    de Zarraga Fernandez, Miguel Alberto
    Bernal, Enrique
    Antonia Sepulveda, Maria
    Vivancos Gallego, Maria Jesus
    Pedrero Tome, Roberto
    Masia Canuto, Mar
    Calderon Hernaiz, Ruth
    Diez Romero, Cristina
    Losa Garcia, Juan Emilio
    Gutierrez Cuadra, Manuel
    Llenas-Garcia, Jara
    Cerezales Calvino, Ana
    Sanchez Guirao, Antonio
    Soler Gonzalez, Josefa
    Estebanez, Miriam
    de la Calle Riaguas, Beatriz
    Angeles Garcinuno, Maria
    Garcinuno Jimenez, Maria Angeles
    Garcia Navarro, Maria del M.
    Ramos Vicente, Noemi
    Clavero Olmos, Marta
    Egido Murciano, Miguel
    Ferreira Pasos, Eva
    Troya Garcia, Jesus
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 66 - 68
  • [3] Cabotegravir plus Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Sension, Michael G.
    Brunet, Laurence
    Hsu, Ricky K.
    Fusco, Jennifer S.
    Cochran, Quateka
    Uranaka, Christine
    Sridhar, Gayathri
    Vannappagari, Vani
    Van Wyk, Jean
    Mccurdy, Lewis
    Wohlfeiler, Michael B.
    Fusco, Gregory P.
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (12) : 2709 - 2724
  • [4] Real-world utilization of cabotegravir/rilpivirine: an observational analysis of adherence and persistence using a patient support programme in Canada, preliminary results
    LaForty, Callahan
    Adelakun, Adenike
    Ng, Ryan
    Chen, Bo
    Trejo, Maria Esther Perez
    Latifovic, Lidija
    Mhishi, Simbarashe
    Ban, Joann
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 158 - 159
  • [5] Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results
    Serris, Alexandra
    Ferre, Valentine Marie
    Le Hingrat, Quentin
    Bachelard, Antoine
    Charpentier, Charlotte
    Exarchopoulos, Marina
    Damond, Florence
    Phung, Bao-Chau
    Landman, Roland
    Yazdanpanah, Yazdan
    Descamps, Diane
    Joly, Veronique
    Peytavin, Gilles
    Ghosn, Jade
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (11) : 2932 - 2938
  • [6] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [7] Long-acting cabotegravir and rilpivirine in HIV individuals with a BMI over 30: a real-world study (RELATIVITY cohort)
    Troya, Jesus
    Morano, Luis
    Ignacio Bernardino, Jose
    Buzon Martin, Luis
    Pedrero Tome, Roberto
    Galindo Puerto, Maria Jose
    Torralba, Miguel
    Cabello Clotet, Noemi
    Garcia Lopez, Maria
    Lope, Silvia
    de Zarraga Fernandez, Miguel Alberto
    Cabello, Alfonso
    Aguilera Garcia, Maria
    Cecilio, Alvaro
    Diaz de Santiago, Alberto
    Garcinuno Jimenez, Maria Angeles
    Bernal, Enrique
    Lopez Caballero, Maria Teresa
    Calderon Hernaiz, Ruth
    Vivancos Gallego, Maria Jesus
    Omiste Sanvicente, Teresa
    Ferreira Pasos, Eva
    Losa Garcia, Juan Emilio
    Soler Gonzalez, Josefa Francisca
    Antonia Sepulveda, Maria
    Garcia Navarro, Maria del Mar
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 92 - 93
  • [8] Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures
    Thoueille, Paul
    Cavassini, Matthias
    Guidi, Monia
    Buclin, Thierry
    Girardin, Francois R.
    Decosterd, Laurent A.
    Marzolini, Catia
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (02):
  • [9] Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Michael G. Sension
    Laurence Brunet
    Ricky K. Hsu
    Jennifer S. Fusco
    Quateka Cochran
    Christine Uranaka
    Gayathri Sridhar
    Vani Vannappagari
    Jean Van Wyk
    Lewis McCurdy
    Michael B. Wohlfeiler
    Gregory P. Fusco
    Infectious Diseases and Therapy, 2023, 12 : 2807 - 2817
  • [10] Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation
    Wood, Brian R.
    Kassaye, Seble G.
    Gerstoft, Jan
    AIDS, 2023, 37 (04) : 689 - 691
12345